Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections.
暂无分享,去创建一个
[1] N. French,et al. Immunologic and clinical stages in HIV-1-infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease. , 1999, Journal of acquired immune deficiency syndromes.
[2] C. Rizza,et al. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population , 1996, The Lancet.
[3] J. Giesecke,et al. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. , 1999, AIDS.
[4] V. Beral,et al. The AIDS incubation period in the UK estimated from a national register of HIV seroconverters , 1998, AIDS.
[5] N. Nagelkerke,et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. , 1995, The Journal of infectious diseases.
[6] J. Kaewkungwal,et al. Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand. , 2000, The Journal of infectious diseases.
[7] C. Rouzioux,et al. High risk of HIV disease progression after infection through a sexual partner with AIDS , 1996, AIDS.
[8] D. Vlahov,et al. African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel , 1997, The Lancet.
[9] D. Vlahov,et al. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[10] E. Karita,et al. Natural History of Human Immunodefiency Virus Type 1 Infection in Children: A Five-Year Prospective Study in Rwanda , 1999, Pediatrics.
[11] Hiv Survival,et al. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.
[12] R. Anderson,et al. Assessing the Potential Impact of the HIV- 1 Epidemic on Orphanhood and the Demographic Structure of Populations in sub-Saharan Africa , 1994 .
[13] C. Giaquinto,et al. REPORT OF A WORKSHOP FOR CLINICAL RESEARCH: Care of human immunodeficiency virus-infected children in developing countries , 1998 .
[14] P. Kaleebu,et al. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort , 2001, AIDS.
[15] S M Gore,et al. Progression of HIV: follow‐up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983–1985 , 1996, AIDS.
[16] Kholoud Porter,et al. Survival after introduction of HAART in people with known duration of HIV-1 infection , 2000, The Lancet.
[17] D J Hu,et al. What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. , 1999, AIDS.
[18] R. Anderson,et al. Mathematical Models of the Transmission and Control of Sexually Transmitted Diseases , 2000, Sexually transmitted diseases.
[19] L. E. Myers,et al. A meta-analysis of estimates of the AIDS incubation distribution , 1996, European Journal of Epidemiology.
[20] J. Kaewkungwal,et al. HIV‐1 incidence determined retrospectively among drug users in Bangkok, Thailand , 1994, AIDS.
[21] J. Whitworth,et al. Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. , 1998, International journal of epidemiology.
[22] J. Karon,et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial , 1999, The Lancet.
[23] M. Quigley,et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study , 2000, The Lancet.
[24] J Giesecke,et al. Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology , 1997, AIDS.
[25] J. Whitworth,et al. An HIV‐1 natural history cohort and survival times in rural Uganda , 1997, AIDS.
[26] J. Pape,et al. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection , 1993, The Lancet.
[27] G. Satten,et al. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis , 1998, AIDS.
[28] F. Wignall,et al. Natural history of HIV infection in Filipino female commercial sex workers. , 1994, Journal of acquired immune deficiency syndromes.
[29] R. Brettle,et al. Do gender differences in CD4 cell counts matter? , 1999, AIDS.
[30] G H Guyatt,et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. , 1999, AIDS.
[31] Roel A. Coutinho,et al. Time from HIV-1 seroconversion to Aids and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis: collaborative Group on Aids incubation and HIV survival including the CASCADE EU concerted action , 2000 .
[32] M. Puoti,et al. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. , 2000, Archives of internal medicine.
[33] M. Melbye,et al. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa , 1997, The Lancet.
[34] P. Yarnold,et al. Supplemental vitamin B and progression to AIDS and death in black South African patients infected with HIV. , 1999, Journal of acquired immune deficiency syndromes.
[35] R. Selik,et al. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. , 2001, JAMA.
[36] H. Coovadia,et al. Are HIV-infected women who breastfeed at increased risk of mortality? , 2001, AIDS.
[37] J. Margolick,et al. Sex differences in HIV-1 viral load and progression to AIDS , 1998, The Lancet.
[38] G. Maartens,et al. Independent epidemics of heterosexual and homosexual HIV infection in South Africa--survival differences. , 1997, QJM : monthly journal of the Association of Physicians.
[39] W Winkelstein,et al. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. , 1996, Annals of epidemiology.
[40] E. Karita,et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. , 1999, Pediatrics.
[41] T. Brown,et al. Country-specific estimates and models of HIV and AIDS: methods and limitations. , 1999, AIDS.
[42] D. Cooper,et al. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. , 1994, American journal of epidemiology.
[43] R. Salamon,et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial , 1999, The Lancet.
[44] I. Thior,et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. , 1999, The Journal of infectious diseases.
[45] A Muñoz,et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. , 1998, JAMA.
[46] Z. Bentwich,et al. Concurrent infections and HIV pathogenesis , 2000, AIDS.
[47] F. Onyango,et al. Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial , 2001, The Lancet.
[48] Noah Kiwanuka,et al. Mortality associated with HIV infection in rural Rakai District, Uganda , 2000, AIDS.
[49] A. Berrebi,et al. Pregnancy and progression to AIDS: results of the French prospective cohorts , 2000, AIDS.
[50] F. Dabis,et al. 18-Month mortality and perinatal exposure to zidovudine in West Africa , 2001, AIDS.
[51] R. Geskus,et al. Differences in Progression to AIDS between Injection Drug Users and Homosexual Men with Documented Dates of Seroconversion , 1996, Epidemiology.
[52] R. Brettle,et al. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe? , 1999, International journal of epidemiology.
[53] J. Alberdi,et al. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival. , 1997, Archives of internal medicine.
[54] H. Lai,et al. High risk of HIV-related mortality is associated with selenium deficiency. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[55] H. Coovadia,et al. Mortality in a cohort of children born to HIV-1 infected women from Durban, South Africa. , 1999, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[56] E. Vittinghoff,et al. Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995. , 1999, American journal of epidemiology.
[57] P. Debré,et al. Early protective effect of CCR‐5 Δ32 heterozygosity on HIV‐1 disease progression: relationship with viral load , 1997 .
[58] John L. Johnson,et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda , 2000, AIDS.
[59] J. Kaewkungwal,et al. Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[60] E. Scheibel,et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. , 1989, BMJ.
[61] M. Farthing,et al. Micronutrient supplementation in the AIDS diarrhoea-wasting syndrome in Zambia: a randomized controlled trial. , 1999, AIDS.
[62] M. Egger,et al. Does pregnancy influence the course of HIV infection? Evidence from two large Swiss cohort studies. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[63] C. Rouzioux,et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV‐infected patients , 1994 .
[64] P. Wright,et al. The natural history of human immunodeficiency virus 1 infection in Haitian infants. , 1999, The Pediatric infectious disease journal.
[65] J. Stephenson,et al. Disease progression and survival in HIV‐1‐infected Africans in London , 1998, AIDS.
[66] J. Pape,et al. HIV infection in Haiti: natural history and disease progression , 2000, AIDS.
[67] D. Bucquet,et al. Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study Group. , 1995, The Journal of infectious diseases.
[68] G. Rutherford,et al. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. , 1990, BMJ.